Immune Activation and CD8+ T-Cell Differentiation towards Senescence in HIV-1 Infection
Open accessThe DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
Progress in the fight against the HIV/AIDS epidemic is hindered by our failure to elucidate the precise reasons for the onset of immunodeficiency in HIV-1 infection. Increasing evidence suggests that elevated immune activation is associated with poor outcome in HIV-1 pathogenesis. However, the basis of this association remains unclear. Through ex vivo analysis of virus-specific CD8(+) T-cells and the use of an in vitro model of naïve CD8(+) T-cell priming, we show that the activation level and the differentiation state of T-cells are closely related. Acute HIV-1 infection induces massive activation of CD8(+) T-cells, affecting many cell populations, not only those specific for HIV-1, which results in further differentiation of these cells. HIV disease progression correlates with increased proportions of highly differentiated CD8(+) T-cells, which exhibit characteristics of replicative senescence and probably indicate a decline in T-cell competence of the infected person. The differentiation of CD8(+) and CD4(+) T-cells towards a state of replicative senescence is a natural process. It can be driven by excessive levels of immune stimulation. This may be part of the mechanism through which HIV-1-mediated immune activation exhausts the capacity of the immune system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Terminally differentiated (CD28−CD57+) T lymphocytes are characterized by strong effector functions such as expression of cytotoxins (e.g., Perforin and Granzyme B) and cytolytic capacity, and a marked inflammatory profile by way of increase proinflammatory cytokine (e.g., IFN-γ, TNF-α, MIP-1β) secretion [86].”
From Aging of the immune system: Focus on inflammation and vaccination (2016) · cites this paper as [86]
Experimental — accuracy not yet measuredIn the citing paper
“The increased proportion of terminally differentiated oligoclonal effector memory T-cell populations in the elderly has been shown to be the consequence of recurrent or chronic immune activation [86].”
From Aging of the immune system: Focus on inflammation and vaccination (2016) · cites this paper as [86]
In the citing paper
“However, terminally differentiated T cells are constrained by limited proliferative capabilities in tandem with short telomeres, and to a large extent, have been defined as approaching senescence [86, 87].”
From Aging of the immune system: Focus on inflammation and vaccination (2016) · cites this paper as [86]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phenotypic Analysis of Antigen-Specific T Lymphocytes
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (1996) · Science · doi:10.1126/science.274.5284.94 · Cited by 3,544 · cited 1×
“HLA–peptide tetrameric complexes (‘‘tetramers’’) were produced as previously described (Altman et al. 1996) and included the following specificity: A2 HIV p17-SLYNTVATL and pol-ILKEPVHGV, A2 CMV pp65-NLVPMVATV, A2 EBV BMLF1-GLCTLVAML, A2 influenza matrix-GILGFVFTL, A2 melanA-ELAGIGILTV, B7 HIV nef-TPGPGVRYPL and gp41-…”
MethodSelf-citationKoup, R. A., Safrit, J. T., Cao, Y., Andrews, C. A., McLeod, G., Borkowsky, W., Farthing, C., & Ho, D. D. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4650-4655.1994 · Cited by 2,495 · cited 1×
“During primary human immunodeficiency virus 1 (HIV-1) infection, the immune system appears to respond appropriately in order to prevent viral spread, with the mounting of a strong HIV-specific CD8þ T-cell response and a corresponding reduction in viraemia (Koup et al. 1994).”
BackgroundCounting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection
Murali-Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J. D., Zajac, A. J., Miller, J. D., Slansky, J., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80470-7 · Cited by 1,943 · cited 1×
“T-cell compartment. Our data indicate that HIV-1 infection results in immune activation not only directly, but also indirectly, with the activation of cells specific for non-HIV antigens. In recent years, the role of potential bystander activation has been reevaluated and is now considered less important (”
BackgroundChanges in thymic function with age and during the treatment of HIV infection
Douek, D. C., McFarland, R. D., Keiser, P. H., Gage, E. A., Massey, J. M., Haynes, B. F., Polis, M. A., Haase, A. T., Feinberg, M. B., Sullivan#, J. L., et al. (1998) · Nature · doi:10.1038/25374 · Cited by 1,893 · cited 1×
“2002c), HIV-infected individuals are characterised by decreased thymic output (Douek et al. 1998) and reduced naı̈ve T-cell numbers (Roederer et al.”
BackgroundLineage relationship and protective immunity of memory CD8 T cell subsets
Wherry, E. J., Teichgräber, V., Becker, T. C., Masopust, D., Kaech, S. M., Antia, R., von Andrian, U. H., & Ahmed, R. (2003) · Nature Immunology · doi:10.1038/ni889 · Cited by 1,864 · cited 1×
“’’ Protective immunity has recently been associated with the proliferative capacity of virus-specific CD8 T-cells in the mouse model (Wherry et al. 2003).”
BackgroundMemory CD8+ T cells vary in differentiation phenotype in different persistent virus infections
Appay, V., Dunbar, P. R., Callan, M., Klenerman, P., Gillespie, G. M. A., Papagno, L., Ogg, G. S., King, A., Lechner, F., Spina, C. A., et al. (2002) · Nature Medicine · doi:10.1038/nm0402-379 · Cited by 1,571 · cited 13×
“One could speculate that the association between different stages of CD8þ T-cell differentiation and viral specificity of these cells, as previously described (Appay et al. 2002a; Tussey et al. 2003), may be related to the stimulation intensity received by the cells from priming onwards.”
BackgroundMethodInfluentialSelf-citationPhenotypic and functional separation of memory and effector human CD8+ T cells
Hamann, D., Baars, P. A., Rep, M. H. G., Hooibrink, B., Kerkhof-Garde, S. R., Klein, M. R., & Lier, R. A. W. V. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1407 · Cited by 1,366 · cited 1×
“The assumption that CD28 /CD27 T-cells are protective effector cells is mainly based on the fact that these cells possess strong cytotoxic potential, expressing high levels of perforin, as seen ex vivo (Hamann et al. 1997).”
BackgroundBorrow, P., Lewicki, H., Wei, X., Horwitz, M. S., Peffer, N., Meyers, H., Nelson, J. A., Gairin, J. E., Hahn, B. H., Oldstone, M. B. A., et al. (1997) · Nature Medicine · doi:10.1038/nm0297-205 · Cited by 1,183 · cited 1×
“Continuous adaptive mutation (Borrow et al. 1997) and destruction or impairment of elements necessary for an optimal immune response (e.”
BackgroundBrenchley, J. M., Karandikar, N. J., Betts, M. R., Ambrozak, D. R., Hill, B. J., Crotty, L. E., Casazza, J. P., Kuruppu, J., Migueles, S. A., Connors, M., et al. (2003) · Blood · doi:10.1182/blood-2002-07-2103 · Cited by 1,073 · cited 4×
“…following priming of T-cells in vitro (see Figure 2C), although this remained relatively modest (below 10%), possibly due to the high susceptibility to activation induced cells death of CD57þ Tcells (Brenchley et al. 2003; unpublished data) in the interleukin-2 (IL-2)-supplemented assay conditions.”
BackgroundInfluentialMigueles, S. A., Laborico, A. C., Shupert, W. L., Sabbaghian, M. S., Rabin, R., Hallahan, C. W., Baarle, D. V., Kostense, S., Miedema, F., McLaughlin, M., et al. (2002) · Nature Immunology · doi:10.1038/ni845 · Cited by 1,005 · cited 1×
“This is supported by Migueles et al. (2002), who showed that HIV-1-infected long-term nonprogressors are characterised by HIV-1-specific CD8þ T-cells that maintain a strong proliferative capacity following in vitro stimulation (cells defined mainly as CD45ROþ/CD28þ/CD27þ early-differentiated cells).”
Background
Research works printed but not linked: 3
- Gerna, 1998, New Microbiol, 21, 293
- Giorgi, 1993, J Acquir Immune Defic Syndr, 6, 904
- Hellerstein, 2003, J Clin Invest, 112, 956, 10.1172/JCI200317533 · doi:10.1172/jci200317533 · Paper page
Cited by
Items 101–200 of 476
Contribution of HIV infection to mortality among cancer patients in Uganda
Coghill, A. E., Newcomb, P. A., Madeleine, M. M., Richardson, B. A., Mutyaba, I., Okuku, F. M., Phipps, W. T., Wabinga, H., Orem, J., & Casper, C. (2013) · AIDS · doi:10.1097/01.aids.0000433236.55937.cb · Cited by 87
Plasmacytoid Dendritic Cells in HIV Infection
O’Brien, M. P., Manches, O., & Bhardwaj, N. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-4433-6_3 · Cited by 95
“…Immune Activation During Chronic HIV Infection HIV infection is marked by aberrant immune activation, which is a better correlate of disease progression to AIDS than viremia (Hazenberg et al. 2003; Deeks et al. 2004; Papagno et al. 2004; Benito et al. 2005; Giorgi et al. 1999; Bofill et al. 1996).”
BackgroundPietersma, F., Piriou, E., & van Baarle, D. (2008) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190801911662 · Cited by 85
“report increased EBV-specific CD8þ T cells during acute HIV infection [75,76].”
BackgroundLichtenstein, K. A., Armon, C., Buchacz, K. A., Chmiel, J. S., Moorman, A. C., Wood, K. C., Holmberg, S. D., & Brooks, J. T. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31815acacc · Cited by 77
Ndhlovu, L. C., Loo, C. P., Spotts, G. E., Nixon, D. F., & Hecht, F. M. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0507281 · Cited by 87
“Immune activation, a normal response to a pathogen, is now recognized as a major driving force of the CD4 T cell depletion in HIV-1 disease [1–8].”
BackgroundIancu, E. M., Corthesy, P., Baumgaertner, P., Devevre, E., Voelter, V., Romero, P., Speiser, D. E., & Rufer, N. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803647 · Cited by 76
Self-citationCD8+ T Cells as a Source of IFN-γ Production in Human Cutaneous Leishmaniasis
Rostami, M. N., Keshavarz, H., Edalat, R., Sarrafnejad, A., Shahrestani, T., Mahboudi, F., & Khamesipour, A. (2010) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000845 · Cited by 76
“CD8 T cells are also important in the control of HIV infection [25–27].”
BackgroundTrautmann, L., Mbitikon-Kobo, F. M., Goulet, J.-P., Peretz, Y., Shi, Y., van Grevenynghe, J., Procopio, F. A., Boulassel, M. R., Routy, J., Chomont, N., et al. (2012) · Blood · doi:10.1182/blood-2012-04-422550 · Cited by 83
DNA – eine vielseitige chemische Verbindung für die Katalyse, zur Kodierung und zur Stereokontrolle
Silverman, S. K. (2010) · Angewandte Chemie · doi:10.1002/ange.200906345 · Cited by 73
Colle, J., Moreau, J. L., Fontanet, A. L., Lambotte, O., Joussemet, M., Jf, D., & Thèze, J. (2006) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2006.03022.x · Cited by 72
The Role of Regulatory T Cells in Chronic and Acute Viral Infections
Keynan, Y., Card, C. M., McLaren, P. J., Dawood, M. R., Kasper, K., & Fowke, K. R. (2008) · Clinical Infectious Diseases · doi:10.1086/529379 · Cited by 85
“These observations are consistent with previous studies demonstrating the unresponsive nature of T cells rendered functionally anergic because of exhaustion in patients with chronic HIV infection [66-68].”
ResultKovács, A., Karim, R., Mack, W. J., Xu, J., Chen, Z., Operskalski, E. A., Frederick, T., LANDAY, A. L., Voris, J. C., SPENCER, L., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/650997 · Cited by 71
“Ongoing antigen-driven activation of CD8 T cells ultimately leads to CD8 T cell exhaustion and replicative senescence, which lead to inability to fight opportunistic pathogens [4].”
BackgroundChouikhi, D., Ciobanu, M., Zambaldo, C., Duplan, V., Barluenga, S., & Winssinger, N. (2012) · Chemistry – A European Journal · doi:10.1002/chem.201201337 · Cited by 71
Programming CD8+ T cells for effective immunotherapy
Hinrichs, C. S., Gattinoni, L., & Restifo, N. P. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.03.009 · Cited by 75
GB virus type C infection modulates T-cell activation independently of HIV-1 viral load
Giret, M. T. M., Silva, T. M., Sauer, M. M., Tomiyama, H. I., Levi, J. E., Bassichetto, K. C., Nishiya, A. S., Diaz, R. S., Sabino, É. C., Palácios, R., et al. (2009) · AIDS · doi:10.1097/qad.0b013e32832d7a11 · Cited by 78
Role of immune activation in HIV pathogenesis
Hunt, P. W. (2007) · Current HIV/AIDS Reports · doi:10.1007/s11904-007-0007-8 · Cited by 77
Aghaeepour, N., Chattopadhyay, P., Chikina, M., Dhaene, T., Van Gassen, S., Kursa, M., Lambrecht, B. N., Malek, M., McLachlan, G. J., Qian, Y., et al. (2016) · Cytometry Part A · doi:10.1002/cyto.a.22732 · Cited by 72
Acutely dysregulated, chronically disabled by the enemy within: T‐cell responses to HIV‐1 infection
Munier, C. M. L., & Kelleher, A. D. (2006) · Immunology and Cell Biology · doi:10.1038/sj.icb.7100015 · Cited by 90
The emerging role of ECM crosslinking in T cell mobility as a hallmark of immunosenescence in humans
Moreau, J.-F., Pradeu, T., Grignolio, A., Nardini, C., Castiglione, F., Tieri, P., Capri, M., Salvioli, S., Taupin, J.-L., Garagnani, P., et al. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.11.005 · Cited by 67
Bystander T cell activation – implications for HIV infection and other diseases
Bangs, S. C., McMichael, A. J., & Xu, X. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.09.006 · Cited by 82
Self-citationCD8 T cell persistence in treated HIV infection
Mudd, J. C., & Lederman, M. M. (2014) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000086 · Cited by 83
“Unlike other viral infections, however, the expansion of the CD8 T cell compartment is not limited only to HIV-reactive cells, and CD8 T cell numbers typically remain elevated throughout the disease course [11,12].”
BackgroundAmyes, E., McMichael, A. J., & Callan, M. F. C. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.5765 · Cited by 65
Self-citationAssessing immune aging in HIV-infected patients
Appay, V., & Sauce, D. (2016) · Virulence · doi:10.1080/21505594.2016.1195536 · Cited by 74
“In this population, CD57C cells, considered as end-stage senescent cells (with the shortest telomeres) also accumulate.(9,10) A similar process occurs for CD4C T cells, although the raise of CD28¡ cells is less obvious in this compartment compared to CD8C”
BackgroundSelf-citationAutoreactive T effector memory differentiation mirrors β cell function in type 1 diabetes
Yeo, L., Woodwyk, A., Sood, S., Lorenc, A., Eichmann, M., Pujol-Autonell, I., Melchiotti, R., Skowera, A., Fidanis, E., Dolton, G. M., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120555 · Cited by 66
Immune Responses to Retroviruses
Sáez‐Cirión, A., & Manel, N. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052155 · Cited by 71
“mitochondrial dysfunction and are prone to apoptosis (81-83, 97, 98).”
BackgroundDysregulation of CD8+ lymphocyte apoptosis, chronic disease, and immune regulation
Wood, K. (2009) · Frontiers in Bioscience · doi:10.2741/3487 · Cited by 64
“Furthermore, CD57 expression by CD8 cells was shown to be a marker of proliferative inability and replicative senescence (5, 6).”
BackgroundPNA Encoding (PNA=peptide nucleic acid): From Solution‐Based Libraries to Organized Microarrays
Harris, J. L., & Winssinger, N. (2005) · Chemistry - A European Journal · doi:10.1002/chem.200500305 · Cited by 71
CD8+ T Cell Senescence: Lights and Shadows in Viral Infections, Autoimmune Disorders and Cancer
Tedeschi, V., Paldino, G., Kunkl, M., Paroli, M., Sorrentino, R., Tuosto, L., & Fiorillo, M. T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063374 · Cited by 71
“Indeed, HIV-1 persistence contributes to a premature immune-senescence [36], often exacerbated by CMV coinfection [37,38], and a higher susceptibility to age-associated multi-morbidity [39].”
BackgroundFernández, S., Price, P., McKinnon, E., Nolan, R. C., & French, M. A. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.04.570 · Cited by 63
Duffau, P., Wittkop, L., Lazaro, E., le Marec, F., Cognet, C., Blanco, P., Moreau, J., Dauchy, F., Cazanave, C., Vandenhende, M. A., et al. (2015) · AIDS · doi:10.1097/qad.0000000000000807 · Cited by 61
Lasso, P., Mateus, J., Pavia, P. X., Rosas, F., Roa, N. L., Thomas, M. C., López, M. C., González, J. M., Puerta, C. J., & Cuéllar, A. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500459 · Cited by 68
“large population of late-differentiated and primarily dysfunctional cells (74).”
BackgroundFali, T., Papagno, L., Bayard, C., Mouloud, Y., Boddaert, J., Sauce, D., & Appay, V. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801475 · Cited by 59
“and are often considered as senescent T cells (7, 8).”
BackgroundSelf-citationDirect Relationship between Virus Load and Systemic Immune Activation in HIV‐2 Infection
Leligdowicz, A., Feldmann, J., Jaye, A., Cotten, M. L., Dong, T., McMichael, A. J., Whittle, H. C., & Rowland-Jones, S. L. (2009) · The Journal of Infectious Diseases · doi:10.1086/648733 · Cited by 60
“posure to high virus levels in chronic infection leads to altered CD8 T cell function and differentiation state, biasing these cells away from an effective cytolytic response and toward the production of deleterious inflammatory cytokines [38, 39].”
BackgroundSelf-citationFunctional impairment of HIV-specific CD8+ T cells precedes aborted spontaneous control of viremia
Collins, D. R., Urbach, J. M., Racenet, Z. J., Arshad, U., Power, K. A., Newman, R. M., Mylvaganam, G., Ly, N. L., Lian, X., Rull, A., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.08.007 · Cited by 63
The memory of a killer T cell: models of CD8+ T cell differentiation
Gerritsen, B., & Pandit, A. (2015) · Immunology and Cell Biology · doi:10.1038/icb.2015.118 · Cited by 69
Multimorbidity, age-related comorbidities and mortality
Duffau, P., Ozanne, A., Bonnet, F., Lazaro, E., Cazanave, C., Blanco, P., Rivière, É., Desclaux, A., Hyernard, C., Gensous, N., et al. (2018) · AIDS · doi:10.1097/qad.0000000000001875 · Cited by 60
The Immune Response Against Human Cytomegalovirus Links Cellular to Systemic Senescence
Heath, J., & Grant, M. D. (2020) · Cells · doi:10.3390/cells9030766 · Cited by 60
“Persons living with HIV (PLWH) are commonly referenced as suffering premature immunosenescence [94].”
BackgroundMiles, D. J. C., Gadama, L. A., Gumbi, A., Nyalo, F., Makanani, B., & Heyderman, R. S. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03186.x · Cited by 61
Blanco, J. R., Caro-Murillo, A. M., Cachafeiro, S. P., Gutiérrez, F., Iribarren, J. A., González‐García, J., Ferrando‐Martínez, S., Navarro, G., & Moreno, S. (2010) · PubMed · Cited by 65
Infection History Determines the Differentiation State of Human CD8 + T Cells
van Aalderen, M. C., Remmerswaal, E. B. M., Verstegen, N. J. M., Hombrink, P., ten Brinke, A., Pircher, H., Kootstra, N. A., ten Berge, I. J. M., & van Lier, R. A. W. (2015) · Journal of Virology · doi:10.1128/jvi.03478-14 · Cited by 54
“As expected, HIV-1 infection strongly influences the characteristics of the CD8 T-cell compartment (34), in that the naive population was smaller in size, whereas the intermediately differentiated and the RA effector-type populations were much larger (Fig.”
BackgroundInfluentialT cell memory and protective immunity by vaccination: is more better?
Zanetti, M., & Franchini, G. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.09.004 · Cited by 60
Human Immunodeficiency Virus and Aging in the Era of Effective Antiretroviral Therapy
Epps, P. V., & Kalayjian, R. C. (2017) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2017.07.007 · Cited by 61
de Silva, T. I., Peng, Y., Leligdowicz, A., Zaidi, I., Li, L. Q., Griffin, H., Blais, M., Vincent, T., Saraiva, M., Yindom, L. ‐., et al. (2013) · Blood · doi:10.1182/blood-2012-12-472787 · Cited by 55
Self-citationChronic HIV disease and activation of the coagulation system
Baker, J. V. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.08.016 · Cited by 58
Keating, S. M., Jacobs, E. S., & Norris, P. J. (2012) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.05.006 · Cited by 53
“capacity and eventual immune senescence [44–46].”
CD8+T-cell-mediated control of HIV-1 and SIV infection
Freel, S. A., Saunders, K. O., & Tomaras, G. D. (2010) · Immunologic Research · doi:10.1007/s12026-010-8177-7 · Cited by 51
Wanjalla, C. N., McDonnell, W. J., Barnett, L. D., Simmons, J. D., Furch, B. D., Lima, M. C., Woodward, B. O., Fan, R., Fei, Y., Baker, P. G., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00408 · Cited by 59
“Age, median yr (IQR) 39 (38, 49) 59 (33, 63) 54 (45, 61) 0.”
The immune system in the aging human
Rymkiewicz, P. D., Heng, Y. X., Vasudev, A., & Larbi, A. (2012) · Immunologic Research · doi:10.1007/s12026-012-8289-3 · Cited by 54
Melkko, S., Mannocci, L., Dumelin, C. E., Villa, A., Sommavilla, R., Zhang, Y., Grütter, M. G., Keller, N., Jermutus, L., Jackson, R. H., et al. (2010) · ChemMedChem · doi:10.1002/cmdc.200900520 · Cited by 56
Martinez, V., Diemert, M., Braibant, M., Potard, V., Charuel, J. L., Barin, F., Costagliola, D. G., Caumes, É., Clauvel, J., Autran, B., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/595013 · Cited by 50
Villar, S. S., Gutiérrez, F., Miralles, C., Berenguer, J., Rivero, A., Martínez, E., & Moreno, S. (2016) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofw097 · Cited by 60
“accepted that HIV-related immunosenescence contributes to disease progression and adverse outcomes [138, 139].”
BackgroundSun, J., Patel, R. C., Zheng, Q., Madhira, V., Olex, A. L., Islam, J. Y., French, E., Chiang, T. P., Akselrod, H., Moffitt, R. A., et al. (2021) · SSRN Electronic Journal · doi:10.1101/2021.07.26.21261028 · Cited by 53
“Furthermore, chronic HIV-related inflammation 33,34 and T-cell senescence 35 might heighten the marked inflammatory response/cytokine storm which may intensify organ damage in severe COVID-19 disease.”
Understanding the mechanisms and limitations of immune control of HIV
Davenport, M. P., Ribeiro, R. M., Zhang, L., Wilson, D. P., & Perelson, A. S. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00485.x · Cited by 49
“Another explanation is that CD8þ T cells become exhausted, possibly because of upregulation of programmed death-1 (51), or progressive senescence of high-affinity responses leads to ‘clonal succession’ toward poorly functional T cells (52, 53).”
BackgroundMutation and control of the human immunodeficiency virus
Stengel, R. F. (2008) · Mathematical Biosciences · doi:10.1016/j.mbs.2008.03.002 · Cited by 49
Mechanisms of immune aging in HIV
Chauvin, M., & Sauce, D. (2022) · Clinical Science · doi:10.1042/cs20210344 · Cited by 56
Day, C. L., Moshi, N. D., Abrahams, D. A., van Rooyen, M., O’rie, T., de Kock, M., & Hanekom, W. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094949 · Cited by 53
“Upregulation of CD57 expression by CD8 T cells in chronic infections has been linked to replicative senescence and greater propensity to antigeninduced apoptosis [54–56].”
BackgroundHIV immunopathogenesis and strategies for intervention
Cadogan, M., & Dalgleish, A. G. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70205-6 · Cited by 60
Campillo-Gimenez, L., Casulli, S., Dudoit, Y., Seang, S., Carcelain, G., Lambert-Niclot, S., Appay, V., Autran, B., Tubiana, R., & Elbim, C. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.05.040 · Cited by 53
Self-citationPickler, L., Beirão, B. C. B., Hayashi, R. M., Durau, J. F., Lourenco, M. C., Caron, L. F., & Santín, E. (2013) · The Journal of Applied Poultry Research · doi:10.3382/japr.2012-00649 · Cited by 44
Schuler, P. J., Macatangay, B. J. C., Saze, Z., Jackson, E. K., Riddler, S. A., Buchanan, W. G., Hilldorfer, B. B., Mellors, J. W., Whiteside, T. L., & Rinaldo, C. R. (2013) · AIDS · doi:10.1097/qad.0b013e328360c7f3 · Cited by 46
“Thus, immune activation could alternatively be due to the preferential depletion of CD4þ T cells in the gut mucosa by HIV-1 infection, leading to enhanced translocation of microbial products to the circulation [14–16]; reactivation of other viruses such as cytomegalovirus [17]; and dysregulation of the T-cell homeosta…”
BackgroundMueller‐Schoell, A., Puebla‐Osorio, N., Michelet, R., Green, M. R., Künkele, A., Huisinga, W., Strati, P., Chasen, B., Neelapu, S. S., Yee, C., et al. (2021) · Cancers · doi:10.3390/cancers13112782 · Cited by 46
Frimpong, A., Kusi, K. A., Adu‐Gyasi, D., Amponsah, J. A., Ofori, M. F., & Ndifon, W. O. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01345 · Cited by 48
“In addition to immune exhaustion, infectious pathogens such as Cytomegalovirus (CMV) and Human Immune deficiency virus (HIV) have been associated with accelerated aging of the body’s immune defense system through the upregulation of CD57, a classical marker for immune senescence (20, 21).”
BackgroundAppay, V., Bosio, A., Lokan, S., Wiencek, Y., Biervert, C., Küsters, D., Devevre, E., Speiser, D., Romero, P., Rufer, N., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7406 · Cited by 41
“In keeping with data showing reduced proliferative capacity and telomere length in CD4 and CD8 T cells along differentiation (35, 36), late differentiation may therefore represent a common state of aged cells and probably the natural end of a T lymphocyte life.”
BackgroundSelf-citationDynamics of the CD8 T‐cell response following yellow fever virus 17D immunization
Co, M. D. T., Kilpatrick, E. D., & Rothman, A. L. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03070.x · Cited by 43
HIV disease progression correlates with the generation of dysfunctional naive CD8low T cells
Favre, D., Stoddart, C. A., Emu, B., Hoh, R., Martin, J. N., Hecht, F. M., Deeks, S. G., & McCune, J. M. (2011) · Blood · doi:10.1182/blood-2010-06-288035 · Cited by 41
HIV infection and atherosclerosis: evaluating the drivers of inflammation
Maniar, A., Ellis, C. L., Asmuth, D. M., Pollard, R. B., & Rutledge, J. C. (2012) · European Journal of Preventive Cardiology · doi:10.1177/2047487312447843 · Cited by 44
“These observations suggest high levels of immune activation targeted towards certain pathogens.(16) Hsue et al.”
BackgroundInfluentialRole of Thymic Output in Regulating CD8 T-Cell Homeostasis during Acute and Chronic Viral Infection
Miller, N. E., Bonczyk, J. R., Nakayama, Y., & Suresh, M. (2005) · Journal of Virology · doi:10.1128/jvi.79.15.9419-9429.2005 · Cited by 41
“Extended periods of proliferation will likely predispose CD8 T cells to activation-induced cell death and possibly replicative senescence (6, 8, 9, 33 , 45).”
BackgroundActivation of NK cells is associated with HIV-1 disease progression
Kuri-Cervantes, L., de Oca, G. S. M., Ávila‐Ríos, S., Hernández‐Juan, R., & Reyes‐Terán, G. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.0913514 · Cited by 51
“HIV-1 pathogenesis is associated with generalized inflammation and activation of innate and adaptive immunity [1–4].”
BackgroundPhysiologic Changes in a Nonhuman Primate Model of HIV-Associated Pulmonary Arterial Hypertension
George, M. P., Champion, H. C., Simon, M. A. M., Guyach, S., Tarantelli, R., Kling, H. M., Brower, A., Janssen, C. F., Murphy, J., Carney, J., et al. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0434oc · Cited by 40
Imaizumi, K., Suzuki, T., Kojima, M., Shimomura, M., Sakuyama, N., Tsukada, Y., Sasaki, T., Nishizawa, Y., Taketomi, A., Ito, M., et al. (2019) · Cancer Science · doi:10.1111/cas.14223 · Cited by 41
“Age (years), median (range) 57 (27-77) 57 (27-72) 61 (33-80) .”
Brainard, D. M., Tager, A. M., Misdraji, J., Frahm, N., Lichterfeld, M. D., Draenert, R., Brander, C., Walker, B. D., & Luster, A. D. (2007) · Journal of Virology · doi:10.1128/jvi.00199-07 · Cited by 48
Onyema, O. O., Decoster, L., Njemini, R., Forti, L. N., Bautmans, I., De Waele, M., & Mets, T. (2015) · BMC Cancer · doi:10.1186/s12885-015-2013-3 · Cited by 38
“Abbreviations 7-AAD: 7-amino actinomycin-D; BSA-PBS: buffering solution; CD: Cisplatin & docetaxel; CDK: Cyclin dependent kinase; CE: Cisplatin & etoposide; CG: Cisplatin & gemcitabine; CMV: Cytomegalovirus; CP: Cisplatin & pemetrexed; CV: Cisplatin & vinorelbine; FITC: Fluorescein isothiocyanate; HIV: Human immunodef…”
BackgroundInfluentialButterfield, T. R., LANDAY, A. L., & Anzinger, J. J. (2020) · Current HIV/AIDS Reports · doi:10.1007/s11904-020-00484-4 · Cited by 41
Fernandes, J. R., Pinto, T. N. C., Arruda, L. B., da Silva, C. C. B. M., Carvalho, C. R. F., Carvalho‐Pinto, R. M., Duarte, A. J. D. S., & Benard, G. (2022) · Immunity & Ageing · doi:10.1186/s12979-022-00267-y · Cited by 41
Leligdowicz, A., Onyango, C. O., Yindom, L. ‐., Peng, Y., Cotten, M. L., Jaye, A., McMichael, A. J., Whittle, H. C., Dong, T., & Rowland‐Jones, S. (2010) · European Journal of Immunology · doi:10.1002/eji.200940295 · Cited by 38
Self-citationImmune Checkpoint Inhibitors in People Living with HIV/AIDS: Facts and Controversies
Castelli, V., Lombardi, A., Palomba, E., Bozzi, G., Ungaro, R., Alagna, L., Mangioni, D., Muscatello, A., Bandera, A., & Gori, A. (2021) · Cells · doi:10.3390/cells10092227 · Cited by 39
“In addition to high levels of circulating viral antigens, the strong pro-inflammatory immune activation during HIV infection and the T-cell subpopulation imbalance during HIV infection contribute to the development of T-cell exhaustion [24,25].”
BackgroundFerrando‐Martínez, S., Ruíz-Mateos, E., Romero-Sánchez, M. C., Muñoz‐Fernández, M. Á., Viciana, P., Genebat, M., & Leal, M. (2011) · Current HIV Research · doi:10.2174/157016211797636008 · Cited by 41
“Immunosenescence has been reported in different HIV scenarios: acute HIV infection [6], HAART-treated individuals [6, 7, 11], virological failure and structured treatment interruptions [12], children [13] or patients with low level of CD4 T-cell repopulation [14].”
BackgroundArrode, G., Finke, J., Zebroski, H. A., Siegal, F. P., & Steinman, R. M. (2004) · European Journal of Immunology · doi:10.1002/eji.200425744 · Cited by 37
Λιούλιος, Γ., Fylaktou, A., Papagianni, A. A., & Stangou, M. J. (2021) · Clinical Immunology · doi:10.1016/j.clim.2021.108685 · Cited by 37
Sinclair, E., Tan, Q. X., Sharp, M., Girling, V., Poon, C., Natta, M. L. V., Jabs, D. A., Inokuma, M. S., Maecker, H. T., Bredt, B. M., et al. (2006) · The Journal of Infectious Diseases · doi:10.1086/508997 · Cited by 36
“x T cells lacking the costimulatory molecule CD28 have a greatly reduced potential for replication, reduced telomerase activity, and reduced telomere length [34, 37, 38].”
Hoji, A., Connolly, N., Buchanan, W. G., & Rinaldo, C. R. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00250-06 · Cited by 38
“More recent studies have found a correlation between an increasing proportion of CD57 HIV-specific CD8 T cells and disease progression (4, 10).”
BackgroundShi, K., Zhao, Y. D., Miao, L., Satterlee, A., Haynes, M. T., Luo, C., Musetti, S., & Huang, L. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.02.008 · Cited by 37
“Creatinine, blood urea nitrogen (BUN), serum aspartate aminotransferase, and alanine aminotransferase were assayed as indicators of renal and hepatic function.(35) Moreover, white blood cells (WBCs), lymphocytes (LYMFs), granulocytes (GRANs), and monocytes (MONOs) were counted for the detection of myelosuppression.”
MethodKoethe, J. R., McDonnell, W. J., Kennedy, A. J., Abana, C. O., Pilkinton, M. A., Setliff, I., Georgiev, I. S., Barnett, L. D., Hager, C. C., Smith, R. M., et al. (2017) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001573 · Cited by 37
Stringer, E. M., Giganti, M. J., Carter, R. J., El‐Sadr, W., Abrams, E. J., & Stringer, J. S. A. (2009) · AIDS · doi:10.1097/01.aids.0000363779.65827.e0 · Cited by 41
Maenetje, P. W., Riou, C., Casazza, J. P., Ambrozak, D. R., Hill, B. J., Gray, G., Koup, R. A., de Bruyn, G., & Gray, C. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903771 · Cited by 35
“differentiation to a more mature memory phenotype that would lead to accumulation of effector cells and premature terminal differentiation (10, 11).”
BackgroundTanko, R. F., Soares, A. P., Masson, L., Garrett, N., Samsunder, N., Karim, Q. A., Karim, S. S. A., Riou, C., & Burgers, W. A. (2018) · Clinical Immunology · doi:10.1016/j.clim.2018.06.001 · Cited by 35
War and Peace between Microbes: HIV-1 Interactions with Coinfecting Viruses
Lisco, A., Vanpouille, C., & Margolis, L. B. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.10.010 · Cited by 36
“Likewise, in CMV/ HIV-1-coinfected individuals, the increase in the fraction of specific CMV-activated T cells and the higher rate of T cell proliferation in response to CMV are associated with accelerated CD4 T cell loss and progression to AIDS (Papagno et al., 2004; Schrier et al., 1996; Waldrop et al., 1997).”
Backgroundvan Baarle, D., Nanlohy, N. M., Otto, S., Plunkett, F. J., Fletcher, J. M., & Akbar, A. N. (2008) · The Journal of Infectious Diseases · doi:10.1086/592170 · Cited by 36
“cells in elderly persons [6, 7].”
The role of TEMRA cell-mediated immune senescence in the development and treatment of HIV disease
Guo, L., Liu, X., & Su, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1284293 · Cited by 47
“The enduring hyper-antigenemia such as HIV, hepatitis C virus (HCV), and CMV during the progressive decline of immune system function results in chronic in fl ammation, ultimately accelerating immune senescence (46, 47).”
BackgroundInflammatory and Immune Mechanisms for Atherosclerotic Cardiovascular Disease in HIV
Hmiel, L., Zhang, S., Obare, L. M., Santana, M. A. D. O., Wanjalla, C. N., Titanji, B. K., Hileman, C. O., & Bagchi, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137266 · Cited by 42
Mojumdar, K., Vajpayee, M., Chauhan, N. K., Singh, A., Singh, R., & Kurapati, S. (2011) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.20610 · Cited by 36
The Expansion and Maintenance of Antigen‐Selected CD8+ T Cell Clones
Fearon, D. T. (2007) · Advances in immunology · doi:10.1016/s0065-2776(07)96003-4 · Cited by 38
“, 2003) and are possibly an important consequence of depletion of CD4þ T cells in HIV-infected patients (Papagno et al., 2004).”
Monitoring cellular immune markers in HIV infection: from activation to exhaustion
Sauce, D., Elbim, C., & Appay, V. (2013) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32835d08a9 · Cited by 48
“With HIV disease progression, the CD4þ and CD8þ T-cell compartments present an accumulation of highly differentiated memory T cells (CD57þ) [70], and importantly, a profound loss of CCR7þ CD27þ CD45RAþ naive T cells [71].”
BackgroundSelf-citationColleton, B. A., Huang, X., Melhem, N. M., Fan, Z., Borowski, L., Rappocciolo, G., & Rinaldo, C. R. (2009) · Journal of Virology · doi:10.1128/jvi.02611-08 · Cited by 34
Byrnes, A. A., Harris, D. M., Atabani, S. F., Sabundayo, B. P., Langan, S. J., Margolick, J. B., & Karp, C. L. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0708438 · Cited by 37
“Our finding that CD4 T cell activation appears blunted from the beginning of HIV infection is consistent with previous reports of absent ex vivo HIV protein-specific, proliferative responses in acute disease [40], and decreased CD38 expression on CD4 compared with CD8 T cells in acute/early HIV infection [4, 28]; howe…”
ResultTherapeutic and prophylactic DNA vaccines for HIV-1
Ramirez, L., Arango, T., & Boyer, J. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.758709 · Cited by 34
“Likewise, chronic HIV-1 infection induces changes in cytokine secretion and exhaustion of CD8 T cells further weakening immune control [70,71].”
BackgroundImmune responses during spontaneous control of HIV and AIDS: what is the hope for a cure?
Sáez‐Cirión, A., Jacquelin, B., Barré‐Sinoussi, F., & Müller-Trutwin, M. C. (2014) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2013.0436 · Cited by 44
Tenets of protection from progression to AIDS: lessons from the immune responses to HIV-2 infection
Leligdowicz, A., & Rowland‐Jones, S. (2008) · Expert Review of Vaccines · doi:10.1586/14760584.7.3.319 · Cited by 35
Self-citationHilchey, S. P., Rosenberg, A. F., Hyrien, O., Secor‐Socha, S., Cochran, M. R., Brady, M. T., Wang, J.-C. E., Sanz, I., Burack, R., Quataert, S. A., et al. (2011) · Blood · doi:10.1182/blood-2011-03-340646 · Cited by 35
Rosenblatt, H. M., Stanley, K., Song, L. Y., Johnson, G. M., WIZNIA, A. A., Nachman, S., & Krogstad, P. A. (2005) · The Journal of Infectious Diseases · doi:10.1086/431597 · Cited by 32
Metadata
- Authors
- Papagno, L., Spina, C. A., Marchant, A., Salio, M., Rufer, N., Little, S., Dong, T., Chesney, G., Waters, A., Easterbrook, P., Dunbar, P. R., Shepherd, D., Cerundolo, V., Emery, V., Griffiths, P., Conlon, C., McMichael, A. J., Richman, D. D., Rowland-Jones, S. L., & Appay, V.
- Affiliations
- University of Milan (IT)
- University of California San Diego (US)
- John Radcliffe Hospital (GB)
- The Royal Free Hospital (GB)
- ORCID
- Venue
- PLoS Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2004-02-17
- Volume
- 2
- Issue
- 2
- Pages
- e20
- ISSN
- 1544-9173 (ISSN-L)
- 1545-7885
- PMC
- PMC340937
- OpenAlex
- W1965845165
- Cited by
- 478
- References
- 71
- Citations by year
- 2026: 10 · 2025: 10 · 2024: 14 · 2023: 10 · 2022: 20 · 2021: 18 · 2020: 13 · 2019: 20 · 2018: 22 · 2017: 21 · 2016: 29 · 2015: 23 · 2014: 22 · 2013: 28 · 2012: 31
- FWCI
- 3.53
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Biology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion, other-oa)
- Funders
- Wellcome Trust
- Cancer Research UK
- King's College London
- European Commission (QLK2-CT)
- National Institutes of Health
- Center for AIDS Research, University of Washington
- University of California, San Diego
- Medical Research Council
- National Institute of Allergy and Infectious Diseases (AI-29164, R24AI106039, R37AI029164)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
- Keywords
- HIV-1 infection, immune activation, CD8+ T cell differentiation, replicative senescence, T cell exhaustion, acute HIV-1 infection, disease progression, CD4+ T cells, virus-specific T cells, T cell priming, immunodeficiency
- MeSH terms
- Aging, Cell Differentiation, Humans, Lymphocyte Activation, CD4-Positive T-Lymphocytes, HIV Infections, CD8-Positive T-Lymphocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.